8:21 PM
Leo Group India
| ||
| Raptor Pharmaceutical: FDA Delay Is A Near-Term Negative, But Immaterial ... iStockAnalyst (By Mani) Raptor Pharmaceutical Corp. (NASDAQ: RPTP) said the FDA delayed the Prescription Drug User Fee Act (PDUFA) date by three months from January 30 to April 30 for Procysbi. Although the delay is a near-term negative event, it would not impact ... See all stories on this topic » | ||
| Separating OHSU faculty from the pharmaceutical industry ignores benefits OregonLive.com Recently, the dean of the school of medicine at Oregon Health & Science University, inspired by a petition from 100 medical students, proposed a ban on faculty participation on pharmaceutical industry speaker boards. The ban, supported by the Program ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment